Association of variation in hepatic lipase activity with promoter variation in the hepatic lipase gene. The LOCAT...

Area of Science:

• Genetics
• Biochemistry
• Cardiovascular Disease Research

Background:

• Hepatic lipase (HL) plays a crucial role in lipoprotein metabolism.
• Genetic variations in the hepatic lipase (LIPC) gene may influence HL activity and lipid profiles.
• Understanding these associations is important for cardiovascular health research.

Purpose of the Study:

• To investigate the associations between LIPC gene polymorphisms and postheparin HL activity.
• To examine the relationship between LIPC polymorphisms and fasting serum lipoprotein levels.
• To determine if LIPC polymorphisms are associated with coronary heart disease in a specific patient cohort.

Main Methods:

• Genotyping of six LIPC gene polymorphisms in 395 male Finnish coronary heart disease patients.
• Measurement of postheparin HL activity.
• Analysis of fasting serum lipoprotein concentrations (HDL, LDL, IDL).
• Statistical analysis to determine associations between genotypes and phenotypes.

Main Results:

• A specific LIPC promoter polymorphism at position -514 was highly significantly associated with HL activity (P = 0.0000008).
• Different genotypes (C/C, C/T, T/T) at LIPC -514 showed distinct mean HL activities.
• Variations at LIPC -514 were associated with triglyceride content in LDL, IDL, and HDL, and cholesterol content in IDL.
• No association was found between the LIPC -514 polymorphism and coronary heart disease.

Conclusions:

• LIPC promoter variation, specifically at position -514, is a likely determinant of HL activity.
• HL activity variations influenced by LIPC genotype underlie observed serum lipoprotein phenotypes.
• This genetic variation impacts lipoprotein profiles but does not appear to be a direct risk factor for coronary heart disease in this population.